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Infectious Risk of Continuous Peripheral Nerve Blocks
Xavier Capdevila, M.D., Ph.D.,* Sophie Bringuier, Pharm.D., M.Sc.,† Alain Borgeat, M.D., Ph.D.‡
CONTINUOUS peripheral nerve block (CPNB) tech-
niques continue to be increasingly used. CPNB catheter
infection is an issue that has received little attention to
date. The frequency of infection associated with periph-
eral nerve catheters remains poorly defined.1–4 Although
the risk of infection during CPNB is a major issue, the
published literature has mainly focused on the conflict-
ing evidence of the frequency of infectious complica-
tions associated with epidural anesthesia. Recent studies
show that between 23 and 57% of peripheral nerve
catheters may become colonized, with 0–3% resulting in
localized infection.1–10 Severe infectious complications
recently reported in the literature include psoas abscess
complicating continuous femoral nerve blocks,1,11 axil-
lary abscess and necrotizing fasciitis5,12 after continuous
and single shot axillary nerve blocks, and thigh and
interscalene abscesses after continuous popliteal sciatic
and interscalene nerve blocks, respectively6,13 (table 1).
An exogenous source of contamination is frequently
suspected. The most frequently detected microorganism
on the skin surface and in colonized catheter is Staphy-
lococcus epidermidis,1–4 whereas Staphylococcus au-
reus is mainly reported in infections or abscess forma-
tion.1,2,5,11,13 Several risk factors, including appropriate
patient selection (intensive care unit or trauma pa-
tients),1,2 catheter site insertion,1–3 prophylactic antibi-
otic use,1,2,5 local anesthetic solution contamination, and
catheter duration,1,2 have been suspected to modify the
risk of infection related to CPNB. The current recom-
mendations to control infectious complications associ-
ated with CPNB are based on existing literature and
guidelines for the prevention of epidural or intravascular
catheter-related infection. The American Society for Re-
gional Anesthesia and Pain Medicine guidelines on this
topic have been published in Regional Anesthesia and Pain
Medicine.14 These recommendations highlighted the im-
portance of asepsis during regional anesthesia needle and
catheter insertion, including handwashing, use of protec-
tive barriers (mask, gloves, gowns, and drapes), and skin
disinfectants. The role of subcutaneous tunneling and of
bacterial filters is still controversial.14 Guidelines for prac-
tice improvement must be built according to specific actual
risk applied to each procedure and certainly cannot be
extrapolated without some restrictions.15 CPNBs are in-
creasing in popularity, and the incidence of infection asso-
ciated with CPNB is thankfully rare. However, infectious
complications will become undoubtedly more common.
This review is to tell the reader what is actually known
about risk factors specific to CPNBs.
Sources of Catheter Colonization
and Infection
The incidence of inflammation and infection associ-
ated with CPNB is low. Exogenous pathogens are sus-
pected as the most likely sources of infection. The skin
area surrounding the perineural catheter insertion site is
the reported origin of the greater majority of colonizing
microorganisms.1–4,16 The predominance of coagulase-
negative Staphylococcus at the perineural catheter tip is
not surprising. This represents colonization of the skin at
the catheter insertion site and the subsequent contami-
nation of the catheter on removal despite aseptic condi-
tions.1 This hypothesis is supported in the study by
Capdevila et al.,1 who showed that 44% of the catheters
were colonized if signs of local inflammation were
present versus 19% when no evidence of inflammation
existed. Some authors14,16 suggest that S. aureus is more
resistant to nonalcoholic disinfectants than other bacte-
ria and that hair follicles and the orifices of sebaceous
glands protect the organism as a result of the lipid
covering of the stratum corneum. The American Society
of Regional Anesthesia and Pain Medicine recommends
the routine use of antiseptic solutions with an alcohol
base for skin disinfection before peripheral regional
techniques due to their penetration of the stratum cor-
neum and their rapid and prolonged effect.14
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Risks Factors for Catheter Infection
There is a great variability in the rate of inflammation
and infection across studies (table 2). A careful analysis
for the reasons for these differences and of the proce-
dures to minimize infection in the low versus high in-
fection rates should be done. Recent studies1,2,4 report
that independent risk factors were associated with cath-
eter colonization and related infection.
A strong risk factor for development of infectious ad-
verse events during CPNB is a stay in the intensive care
unit (ICU). In the ICU, most of the patients studied had
sustained major trauma. It has been suggested that
trauma ICU patients have a greater number of skin bac-
terial species than other patients and that inadequate and
difficult working conditions and environment prevent a
total aseptic technique during catheter insertion.2 More-
over, compromised cellular immunity, which frequently
develops in the ICU patients, may contribute to the
higher risk of infection. Neuburger et al.2 claimed that
the high incidence of local inflammation and infection
observed in their study is explained by large number of
trauma patients (30%). However, in Capdevila et al. study,1
the stay in ICU is an independent risk factor for local
inflammation. This factor is independent from the group of
trauma patients. All the catheters in that study were put in
before ICU admission in surgical and trauma patients. An-
esthesiologists should be aware of the increased risk of
catheter-related infection in the subgroup of ICU patients.
Duration of catheter also seems to be an important risk
factor of local infectious problems. Capdevila et al.1
reported that CPNB of duration longer than 48 h was an
independent risk factor for local inflammation and catheter-
related local infection (odds ratio [95% CI], 4.61 [1.57–
15.9]). Capdevila et al.1 noted 3% of local inflammation
defined by focal pain, redness, and induration, and only
one case of systemic infection (psoas muscle abscess). We
analyzed the incidences of local inflammation for each
period of time in the 1416 patients of Capdevila’s study and
report them in table 3. Interestingly the incidence of in-
flammation increased significantly for each studied period,
except for the 24-h selected threshold. The longer that the
CPNB catheter is still in place, the more the risk of local
inflammation is important. In the same study, we calcu-
lated the adjusted odds ratio for local inflammation and
signs of infection as a function of every 24-h time period.
The results are reported in figure 1. After the 48-h period,
if we consider odds ratio, the risk of local inflammation
and/or infection signs increases for each time period con-
sidered. Similarly, Neuburger et al.2 observed a relation
between the mean duration of catheter use 5 (range, 2–18)
days and the patients having an infection requiring surgical
drainage. Noninfected patients had a mean catheter use
duration of 4 (range, 1–36) days.
The absence of antibiotic prophylaxis was noted to be
an independent risk factor for local inflammation.1,2,5 In
a series of 405 continuous axillary blocks, the only
abscess occurred in a patient who had not received
antibiotics.5 That patient was scheduled in a rehabili-
tation program after a chronic pain syndrome. Eigh-
teen patients did not receive the usual 2 days of antibiotic
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therapy. Morin et al.4 reported that the use of an antibiotic
in the postoperative period can limit the risk of local infec-
tion. However it appears that a single dose of antibiotics
injected 30 to 60 min after catheter insertion probably does
not provide sufficient protection.5
The site of catheter insertion can be another potential
risk factor for bacterial colonization. The femoral or
axillary sites are associated with a rate of catheter bac-
terial colonization as high as 37% to 57%,1,3 whereas the
popliteal catheter has a reduced colonization rate of
between 0% to 19%.1,4,17 This finding may be related to
the density of sebaceous glands in the groin or the axilla,
which has been shown to affect the ability of disinfec-
tion to decrease the percentage of microrganisms.16 We
analyzed the incidence of local inflammation for CPNBs
at the most common sites of placement as a function of
every 24-h time period in the Capdevila et al. study.1 The
results are reported in figure 2. As for the catheter
colonization, the incidence of local inflammation is re-
lated to the duration of the catheter and to the location.
The femoral/fascia iliaca compartment and axillary con-
tinuous blocks are associated with the higher rate of
patients’ local inflammation. Morin et al.4 highlighted
the fact that catheter placement in the groin can increase
the risk of a local inflammation. The authors reported an
odd ratio at 3.4 (1.5–7.8) for this parameter in compar-
ison with other catheter locations.
Male sex seems significantly associated with an in-
creased risk of local inflammation.1 In studies by Cap-
devila et al.1 and Morin et al.,4 age, underlying disease
(diabetes mellitus, cancer, infectious disease, steroid
therapy), and technically difficult catheter insertion
were not associated with an increased risk of local in-
flammation or infection. However, these statements
were not clearly supported by power analysis.
In the majority of studies investigating the infectious
risk of CPNB, the anesthesiologists have worn a hat,
surgical mask, gloves and gown and have prepared the
CA
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skin with disinfectants and sterile drapes. This fact prob-
ably partially explains the very low incidence of infec-
tion during CPNB.
Table 4 describes the risk factors for peripheral nerve
block catheter inflammation based on clear evidence in
the literature, unproved factors, and those that are
proven not to be a risk factor.
Different Aspects of Aseptic Techniques
Studies show that both equipment and local anesthetic
solutions can become contaminated.18
Rituals and myths regarding aseptic technique per-
formed by anesthesiologists abound in the operating
room. Woodhead et al.18 reported that only 12% of
Fig. 1. Odds ratio for local inflammation
and/or signs of infection as a function of
every 24-h time period for all the contin-
uous peripheral nerve block catheters.
From Capdevila et al.1
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physicians based infection control practice in the oper-
ating room on evidence-based medicine data.
There is good evidence that the risk of central ve-
nous catheter infection is reduced by the use of a
technique involving surgical type aseptic conditions
compared with hand washing and sterile gloves
alone.19,20 Therefore, this method should be applied
to CPNB techniques.
The American Society for Regional Anesthesia and Pain
Medicine recommendations14 discuss hand cleansing,
jewelry, gloves, gowns, masks, bacterial filter, antiseptic
prep solutions and methods of applying them, and
Fig. 2. Incidences of local inflammation
as a function of every 24-h time period at
four selected sites of continuous periph-
eral nerve block catheters. The incidences
increase if we consider axillary and femo-
ral/fascia iliaca compartment (FIC) loca-
tions. From Capdevila et al.1 SN  sciatic
nerve.
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drapes or dressings at the catheters sites. They are re-
ported in table 5. These are generic recommendations
regarding single shot and continuous regional anesthetic
techniques, and the authors commented that little is
known regarding CPNBs. However, it seems reasonable
to apply these recommendations to CPNB techniques.
Other specific parameters like catheter tunneling, spe-
cific dressing, and infusate contamination can be dis-
cussed separately. The dressing around a CPNB catheter
minimizes the risk of premature displacement and al-
lows inspection of the catheter skin entry point (local
inflammation) if transparent. Visible local inflammation,
even without pus, is associated with an increase in
catheter colonization.1,2 However, we have seen that
high catheter colonization rates are not related to deep
infection or abscesses.1–3 In contrast, the absence of skin
inflammation does not mean that there is no bacterial
catheter colonization. The transparent dressing is imper-
meable, resulting in the underlying skin becoming moist
and allowing the growth of organisms. On the other
hand, a totally porous dressing can maximize the site
access to bacteria. Another way of decreasing skin col-
onization is to place antiseptic around the puncture site
or to use antiseptic dressings. The rationale of this prac-
tice is to prevent the regeneration of skin microorgan-
isms in the hours after the initial antiseptic application.
Iodine-based powders or creams can be used, but they
tend to reduce dressing adhesion. Catheter tunneling has
the theoretical advantage of decreased catheter move-
ment and decreased spread of infection. There are sev-
eral techniques for tunneling CPNB catheters using 17-
to 18-gauge tuohy or 18-gauge IV needles with or with-
out a plastic cannula.21,22 Borgeat et al.6,21 used a lateral
modified approach for continuous interscalene blocks
and tunneled the interscalene catheter. They reported
no catheter dislodgement in 700 patients and 1% of
patients with signs and symptoms of local infection.
Capdevila et al.1 in 1416 CPNB did not tunnel the cath-
eters and reported 11% of catheter accidental with-
drawal and 3% of local inflammation signs. A recent
study in 402 patients with CPNBs highlighted the inter-
est of catheter tunneling.23 The authors reported a col-
onization incidence of 6.22% (3.8–8.5%), with a micro-
biologic analysis of the catheter tip cultures revealing
coagulase negative Staphylococcus in 72%. Therefore, it
appears that subcutaneous tunneling seems beneficial in
reducing clinically relevant movements of the catheters
and perhaps in providing an extra benefit regarding the
development of CPNB catheter site colonization. The
infusate can be the source of infection, although it is
thought to be the least important because the solutions
of local anesthetics have some antibacterial activity.24
The risks of infusate contamination may increase with
frequent changes of the catheter hub, with syringes
repeatedly changed in surgical ward by nurses without
masks, hats, and gloves and in long-term continuous
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regional blocks.18 Kirschke et al.25 reported S. aureus
joint and soft-tissue infections occurring in outpatients
after therapeutic intraarticular injections. In 17 patients,
3 were subsequently hospitalized for infections. All of
these patients received triamcinolone-lidocaine solu-
tions. The multiple-dose vial of lidocaine was contami-
nated with S. aureus. It seems reasonable to use large
volume bags of regional block infusate prepared by the
pharmacy or reputable supplier/industrial firm and to be
aware of the infusate preparation conditions in the op-
erating theaters, postanesthetic care units, or surgical
wards.
Conclusion
Risk factors are perfectly demonstrated to be related to
local inflammation or infection during CPNB techniques.
There are duration of the continuous infusion more than
48 h, the absence of antibiotic prophylaxy, the stay in
ICU for a patient, and axillary or femoral location of the
catheter. The coagulase-negative Staphylococcus is pre-
dominantly noted at the perineural catheter tip. Al-
though definitive proof is lacking, there is strong evi-
dence that the maximal sterile precautions used for
epidural insertion can be recommended to anesthesiol-
ogists for CPNB. The American Society of Regional An-
esthesia recommendations are based on clinical evi-
dence for some and theoretical rationale for others.
Caregivers should be aware of risk factors for inflamma-
tion and possibly for infection with CPNB.
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